218 related articles for article (PubMed ID: 28847706)
21. Botulinum toxin A (Botox) injection into muscles of pelvic floor as a treatment for persistent pelvic pain secondary to pelvic floor muscular spasm: A pilot study.
Mooney SS; Readman E; Hiscock RJ; Francis A; Fraser E; Ellett L
Aust N Z J Obstet Gynaecol; 2021 Oct; 61(5):777-784. PubMed ID: 34128537
[TBL] [Abstract][Full Text] [Related]
22. High-Density Surface Electromyography Assessment of Pelvic Floor Dysfunction in Women with Interstitial Cystitis/Bladder Pain Syndrome.
Dias N; Zhang C; Spitznagle T; Lai HH; Zhang Y
J Urol; 2020 Dec; 204(6):1275-1283. PubMed ID: 32628100
[TBL] [Abstract][Full Text] [Related]
23. Mindfulness in Facilitating Pelvic Floor Botulinum Toxin Injection in Women with Chronic Pelvic Pain.
Aredo JV; Tandon HK; Panahi S; Phan VT; Ameli R; Karp BI; Stratton P
Toxins (Basel); 2024 May; 16(5):. PubMed ID: 38787068
[TBL] [Abstract][Full Text] [Related]
24. Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles.
Jarvis SK; Abbott JA; Lenart MB; Steensma A; Vancaillie TG
Aust N Z J Obstet Gynaecol; 2004 Feb; 44(1):46-50. PubMed ID: 15089868
[TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin injection for chronic pelvic pain: A systematic review.
Luo FY; Nasr-Esfahani M; Jarrell J; Robert M
Acta Obstet Gynecol Scand; 2020 Dec; 99(12):1595-1602. PubMed ID: 32597494
[TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial.
Abbott JA; Jarvis SK; Lyons SD; Thomson A; Vancaille TG
Obstet Gynecol; 2006 Oct; 108(4):915-23. PubMed ID: 17012454
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of botulinum toxin a injections in pelvic floor muscles in chronic pelvic pain patients: a systematic review and meta-analysis.
Spruijt MA; Klerkx WM; Kelder JC; Kluivers KB; Kerkhof MH
Int Urogynecol J; 2022 Nov; 33(11):2951-2961. PubMed ID: 35362767
[TBL] [Abstract][Full Text] [Related]
28. Botulinum toxin for pelvic pain in women.
Sinha D; Thomson AJ
Womens Health (Lond); 2008 Mar; 4(2):173-81. PubMed ID: 19072519
[TBL] [Abstract][Full Text] [Related]
29. High-density surface electromyographic assessment of pelvic floor hypertonicity in IC/BPS patients: a pilot study.
Dias N; Zhang C; Smith CP; Lai HH; Zhang Y
Int Urogynecol J; 2021 May; 32(5):1221-1228. PubMed ID: 32761375
[TBL] [Abstract][Full Text] [Related]
30. Botulinum toxin for conditions of the female pelvis.
El-Khawand D; Wehbe S; Whitmore K
Int Urogynecol J; 2013 Jul; 24(7):1073-81. PubMed ID: 23344218
[TBL] [Abstract][Full Text] [Related]
31. [First experience of using lantox (botulinum toxin A) in chronic pelvic pain syndrome combined with bladder emptying dysfunction].
Krivoborodov GG; Shumilo DV; Vasil'ev AV
Urologiia; 2010; (2):60-2. PubMed ID: 20973143
[TBL] [Abstract][Full Text] [Related]
32. Re: A pilot study of botulinum toxin a for male chronic pelvic pain syndrome.
Berger RE
J Urol; 2011 Apr; 185(4):1303. PubMed ID: 22098965
[No Abstract] [Full Text] [Related]
33. Transvaginal Trigger Point Injections Improve Pain Scores in Women with Pelvic Floor Hypertonicity and Pelvic Pain Conditions.
Bartley J; Han E; Gupta P; Gaines N; Killinger KA; Boura JA; Farrah M; Gilleran J; Sirls LT; Peters KM
Female Pelvic Med Reconstr Surg; 2019; 25(5):392-396. PubMed ID: 29621041
[TBL] [Abstract][Full Text] [Related]
34. A pilot study of botulinum toxin A for male chronic pelvic pain syndrome.
Gottsch HP; Yang CC; Berger RE
Scand J Urol Nephrol; 2011 Feb; 45(1):72-6. PubMed ID: 21062115
[TBL] [Abstract][Full Text] [Related]
35. Intravaginal Diazepam for the Treatment of Pelvic Floor Hypertonic Disorder: A Double-Blind, Randomized, Placebo-Controlled Trial.
Holland MA; Joyce JS; Brennaman LM; Drobnis EZ; Starr JA; Foster RT
Female Pelvic Med Reconstr Surg; 2019; 25(1):76-81. PubMed ID: 29280763
[TBL] [Abstract][Full Text] [Related]
36. The Benefits and Harms of Botulinum Toxin-A in the Treatment of Chronic Pelvic Pain Syndromes: A Systematic Review by the European Association of Urology Chronic Pelvic Pain Panel.
Parsons BA; Goonewardene S; Dabestani S; Pacheco-Figueiredo L; Yuan Y; Zumstein V; Cottrell AM; Borovicka J; Dinis-Oliveira P; Berghmans B; Elneil S; Hughes J; Messelink BEJ; de C Williams AC; Baranowski AP; Engeler DS
Eur Urol Focus; 2022 Jan; 8(1):320-338. PubMed ID: 33526405
[TBL] [Abstract][Full Text] [Related]
37. The application of botulinum toxin in the prostate.
Chuang YC; Chancellor MB
J Urol; 2006 Dec; 176(6 Pt 1):2375-82. PubMed ID: 17085104
[TBL] [Abstract][Full Text] [Related]
38. Ischiorectal fossa abscess after pelvic floor injection of botulinum toxin.
Brueseke TJ; Lane FL
Am J Obstet Gynecol; 2012 Mar; 206(3):e7-8. PubMed ID: 22381609
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the levator ani and pelvic wall muscles in levator ani syndrome.
Hull M; Corton MM
Urol Nurs; 2009; 29(4):225-31. PubMed ID: 19718937
[TBL] [Abstract][Full Text] [Related]
40. A review of botulinum toxin use for chronic pelvic pain syndrome.
Gottsch HP; Yang CC; Berger RE
Curr Urol Rep; 2010 Jul; 11(4):265-70. PubMed ID: 20446070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
